Guggenheim Upgrades Avista (AVA) to Neutral

Guggenheim analyst Shahriar Pourreza upgraded Avista (NYSE: AVA) from Sell to Neutral with a price target of $34.00 (from $32.00).

For an analyst ratings summary and ratings history on Avista click here. For more ratings news on Avista click here.

Shares of Avista closed at $33.66 yesterday.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Lowered to $70 at JPMorgan Amid Negative Sentiment
• Tyra Biosciences (TYRA) PT Lowered to $29 at H.C. Wainwright
• Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens